The landscape of diabetes care is changing with the introduction of GLP-1 patches . These novel patches offer a likely simpler alternative to needle administrations for individuals managing diabetes 2. Such a system deliver glucagon-like peptide-1 directly through the epidermis, bypassing the requirement for regular injections and potentially impro